INMB vs. CYN
INMB (INmune Bio, Inc.) and CYN (CYNGN Inc.) are both stocks. INMB operates in Biotechnology (Healthcare), while CYN operates in Software - Application (Technology). Over the past 3 years, INMB returned -46.06%/yr vs -95.88%/yr for CYN. At a 0.18 correlation, their price movements are largely independent.
Performance
INMB vs. CYN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INMB achieves a -8.33% return, which is significantly higher than CYN's -50.42% return.
INMB
- 1D
- -1.38%
- 1M
- -1.38%
- YTD
- -8.33%
- 6M
- -23.94%
- 1Y
- -77.59%
- 3Y*
- -46.06%
- 5Y*
- -40.35%
- 10Y*
- —
CYN
- 1D
- -7.09%
- 1M
- -17.48%
- YTD
- -50.42%
- 6M
- -62.78%
- 1Y
- -70.50%
- 3Y*
- -95.88%
- 5Y*
- —
- 10Y*
- —
INMB vs. CYN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
INMB INmune Bio, Inc. | -8.33% | -66.60% | -58.53% | 77.60% | -37.84% | -44.11% |
CYN CYNGN Inc. | -50.42% | -98.13% | -94.13% | -76.37% | -85.03% | -43.82% |
Correlation
The correlation between INMB and CYN is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2021 | 0.18 |
Fundamentals
INMB:
$38.02M
CYN:
$12.99M
INMB:
-$1.61
CYN:
-$4.23
INMB:
1.94
CYN:
0.26
INMB:
$0.00
CYN:
$276.40K
INMB:
-$108.00K
CYN:
$95.11K
INMB:
-$26.72M
CYN:
-$25.99M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INMB vs. CYN — Risk / Return Rank
INMB
CYN
INMB vs. CYN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for INmune Bio, Inc. (INMB) and CYNGN Inc. (CYN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INMB | CYN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.42 | ||
| Sortino ratioReturn per unit of downside risk | -1.09 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.00 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | -0.76 | -0.16 |
| Martin ratioReturn relative to average drawdown | -1.02 | -0.91 | -0.11 |
Loading charts...
Drawdowns
INMB vs. CYN - Drawdown Comparison
The maximum INMB drawdown since its inception was -95.98%, roughly equal to the maximum CYN drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for INMB and CYN.
Loading charts...
Drawdown Indicators
| INMB | CYN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.98% | -100.00% | +4.02% |
Max Drawdown (1Y)Largest decline over 1 year | -84.80% | -92.77% | +7.97% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | -99.99% | +7.98% |
Max Drawdown (5Y)Largest decline over 5 years | -95.98% | — | — |
Current DrawdownCurrent decline from peak | -94.87% | -100.00% | +5.13% |
Average DrawdownAverage peak-to-trough decline | -60.75% | -90.65% | +29.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 75.79% | 77.32% | -1.53% |
Volatility
INMB vs. CYN - Volatility Comparison
INmune Bio, Inc. (INMB) has a higher volatility of 17.60% compared to CYNGN Inc. (CYN) at 15.74%. This indicates that INMB's price experiences larger fluctuations and is considered to be riskier than CYN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INMB | CYN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.60% | 15.74% | +1.86% |
Volatility (6M)Calculated over the trailing 6-month period | 51.12% | 67.11% | -15.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.62% | 198.29% | -98.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.62% | 197.41% | -111.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 92.70% | 197.41% | -104.71% |
Dividends
INMB vs. CYN - Dividend Comparison
Neither INMB nor CYN has paid dividends to shareholders.
Financials
INMB vs. CYN - Financials Comparison
This section allows you to compare key financial metrics between INmune Bio, Inc. and CYNGN Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INMB and CYN have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INMB has higher volatility (17.60%) compared to CYN (15.74%). In terms of maximum drawdown, INMB dropped -95.98% vs CYN's -100.00%.
CYN currently has the higher Sharpe Ratio (-0.36 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INMB and CYN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer